Navigation Links
Acutus Medical Closes Series B Funding at $28 Million
Date:8/20/2013

/p>

Acutus Medical believes that its technology may eventually play a significant role in improving the lives of countless individuals who are afflicted by AF.

This press release includes forward-looking statements regarding Acutus Medical Cardiac Imaging and Mapping Technology System.  Any statement describing Acutus Medical's goals, expectations, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Acutus goals.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing products and in the endeavor of building a business around such products.  Acutus Medical's forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Acutus Medical forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Acutus Medical. As a result, you are cautioned not to rely on these forward-looking statements.

PR Contact:  Randy Werneth, acutuspr@acutusmedical.com


'/>"/>
SOURCE Acutus Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Acutus Medical, Inc. bringt 21 Millionen $ für die Serie-B-Finanzierung auf
2. Acutus Medical, Inc. Raises $21 Million Toward its B-Series Financing
3. Acutus Medical, Inc. erprobt erstmals seinen Echtzeit-3D-Bildgebungskatheter von CT/MRI-Qualität in einer klinischen Studie am Menschen
4. Acutus Medical, Inc. lance la première étude clinique sur lhomme dun cathéter à imagerie 3D en temps réel offrant une qualité comparable aux TDM/IRM
5. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
6. Intellectual Property Insurance for the Medical-Related Products Industry
7. X-Change Corporation Signs Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Consulting
8. First German Patient enrolled pushes ROX Medical Past Halfway Point in CONTROL-HTN trial
9. CompuGroup Medical US Announces New Laboratory Information System for the Reference Laboratory, CGM ENDEAVOR
10. Medical Device Recalls Reach Five-Quarter High in ExpertRECALL Index
11. ParagonRx, An inVentiv Health Company, Names Former U.S. Food And Drug Administration Official To Position Of Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... BALTIMORE , April 20, 2015  Ameritox,s Ingenuity ... health clinicians, today presented clinical research at the National ... Orlando, Fla. , showing that nearly 25 percent ... illness (SMI) did not contain the prescribed antipsychotic medication. ... - http://photos.prnewswire.com/prnh/20150420/199663LOGO ...
(Date:4/20/2015)... , April 20, 2015  U.S. pharmacy cost increases ... to drift into the low double-digits by 2016, according to ... retirement and health solutions business of Aon plc ... changes are projected to be 9.5 percent in 2015 and ... Aon Hewitt predicts a similar rate of increase in ...
(Date:4/20/2015)... , April 20, 2015 Eli Lilly ... the investigational medicine ixekizumab was statistically superior to placebo ... (PsA), as demonstrated by the proportion of patients achieving ... assessment that represents a 20 percent reduction in disease ... of Rheumatology response criteria. During the 24-week, Phase 3 ...
Breaking Medicine Technology:Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4
... Inc. (Nasdaq: STRM ) today announced financial ... ended January 31, 2011. Highlights for the ... purchase contracts for add-on licenses with existing clients totaling ... recognized during the quarter; Company completed and ...
... N.J., April 12, 2011 Novartis Pharmaceuticals Corporation ... Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) ... treatment of patients with advanced neuroendocrine tumors (NET) ... provided after presentation of data from the everolimus ...
Cached Medicine Technology:Streamline Health® Solutions Reports Q4 Results 2Streamline Health® Solutions Reports Q4 Results 3Streamline Health® Solutions Reports Q4 Results 4Streamline Health® Solutions Reports Q4 Results 5Streamline Health® Solutions Reports Q4 Results 6Streamline Health® Solutions Reports Q4 Results 7Streamline Health® Solutions Reports Q4 Results 8Streamline Health® Solutions Reports Q4 Results 9Streamline Health® Solutions Reports Q4 Results 10Streamline Health® Solutions Reports Q4 Results 11Streamline Health® Solutions Reports Q4 Results 12Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
(Date:4/20/2015)... When author Faith Canter was diagnosed ... if nothing could wake her up - and she wasn’t ... are currently living with CFS. , Rather than accepting her ... Living a Life Less Toxic : The Whole Life Approach ... Happier, Healthier Life for You, Your Family and Our Planet.” ...
(Date:4/20/2015)... Heritage Woods of Centralia, a Gardant ... and Dine-and-Dash Spaghetti Dinner from 4 p.m. to 6 ... located in Centralia, Illinois, houses senior living apartments, affordable ... 55 and older. , Guests are invited to tour ... options for seniors. After the tours, they can take ...
(Date:4/20/2015)... 2015 Construction has reached completion ... Draft, an independent, nonprofit community hospital with existing ... The project was an ongoing collaboration between Timmons ... is expected to provide additional employment opportunities for ... Highway, the new facility features physician offices, a ...
(Date:4/20/2015)... April 21, 2015 Using Quality by ... Speed Production and Improve Compliance , **FDAnews Webinar**, May ... http://www.fdanews.com/qualitybydesign , The life sciences industries are ... to do more with less. Mergers, acquisitions, the ... to finds ways to speed up production while still ...
(Date:4/20/2015)... Is it possible to create measures of ... the local needs of the providers, payers and patients who ... over the past year by the Hutchinson Institute for Cancer ... Center in Seattle, Washington. , In a new commentary ... Journal of Managed Care, HICOR Director Scott Ramsey, MD, ...
Breaking Medicine News(10 mins):Health News:New book by Faith Canter offers guide to banishing toxins 2Health News:Heritage Woods of Centralia Senior Living Community to Host Open House and Spaghetti Dinner 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 3Health News:Creating Value Metrics in Cancer Care From the Bottom Up 2Health News:Creating Value Metrics in Cancer Care From the Bottom Up 3
... to a major disaster should focus on three consecutive missions: ... aid, according to research presented Sunday, Oct. 3, at the ... San Francisco. In January, within 24 hours of ... States Naval Ship (USNS) Comfort was deployed to Haiti. With ...
... was higher among adults in Puerto Rico compared to ... was lower, according to data presented at the Third ... held Sept. 30 to Oct 3, 2010. Genetic ... and other venues, providing individual access to genetic tests ...
... Hopkins Medicine, Johns Hopkins scientists have discovered a way to ... proteins in mice, a discovery that could have implications for ... such as peanuts and milk. The findings, published online ... the body could be trained to tolerate food allergies that ...
... instrument due to fly aboard NASA,s James Webb Space Telescope ... facilities at the Rutherford Appleton Laboratory (RAL) in the United ... to areas of investigation as diverse as the first light ... other stars. "The start of space simulation testing ...
... A UC Irvine infectious disease specialist has received a ... methods to prevent staph infections in people who harbor MRSA ... Agency for Healthcare Research & Quality awarded Huang the grant ... American Recovery & Reinvestment Act of 2009. CHOICE grants will ...
... Boston Medical Center (BMC) doctors have proven the ... tool that assesses the cleanliness of the colon during ... of the journal Gastrointestinal Endoscopy , demonstrates the ... to rate colon cleanliness during colonoscopy. Audrey ...
Cached Medicine News:Health News:Operation Unified Response: 3 phases of disaster care in Haiti 2Health News:Adults in Puerto Rico aware of genetic testing, but use remains low 2Health News:Johns Hopkins researchers turn off severe food allergies in mice 2Health News:NASA's Webb telescope MIRI instrument takes one step closer to space 2Health News:NASA's Webb telescope MIRI instrument takes one step closer to space 3Health News:NASA's Webb telescope MIRI instrument takes one step closer to space 4Health News:UCI gets major funding to study ways of preventing drug-resistant staph infections 2Health News:Boston Medical Center research study validates the Boston Bowel Preparation Scale 2
... SureFlex™ line of reusable and autoclavable Lithotripsy ... This revolutionary and patented termination method accepts ... In the unlikely event you do manage ... face absolutely prevents damage to your laser ...
ELVeS™ (Endo Laser Vein System) from biolitec is a versatile, easy to use & complete system that allows you to treat all conditions resulting from venous incompetence. (ELVeS has FDA clearance ...
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
One piece, 100% fused silica construction offers low scatter and high efficiency...
Medicine Products: